Phraxis
Minneapolis
About Phraxis
Phraxis is a medical device company, develops treatment solutions for patients who need vascular access to enable hemodialysis. The company offers InterGraft, a percutaneously delivered arterio-venous shunt that provides a non-surgical approach for patients who need vascular access. It also develops devices for interventional nephrology to enable physicians to manage their dialysis patients. The company was incorporated in 2008 and is based in St. Paul, Minnesota.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $12.4M
- Funding stage: Late Stage Venture
- Last round: Series D (Mar 2022)
- Website: phraxis.com
- Phone: 6516364642
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/phraxis-119930 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.